Hospital
Providence Health & Services Oregon
Providence Health & Services Oregon was paid $8.01M by Medicaid between Jan 2018 and Nov 2024, across 55 billing codes. Its largest line is 99283, emergency room visit (moderate) — 35% of everything it billed.
33Billing provider infoPROVIDENCE HEALTH & SERVICES OREGON
SEASIDE, OR 97138
SEASIDE, OR 97138
33aNPI1578500492assigned 05/31/2006
33bProvider typeCritical Access Hospital
28Total paid$8.01M
24GClaims64,108
24DCodes billed55
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Oregon
Rank by total paid#10 of 22
Median peer was paid$3.52M
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,558 | $1.34M | |
| 2019 | 8,224 | $1.01M | |
| 2020 | 7,611 | $889K | |
| 2021 | 9,940 | $1.03M | |
| 2022 | 11,980 | $1.35M | |
| 2023 | 9,473 | $1.29M | |
| 2024incomplete | 5,322 | $1.11M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 35% | 13,817 | 8,684 | $2.81M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 32% | 8,996 | 5,814 | $2.56M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 21% | 4,049 | 2,422 | $1.70M |
| 80053 | Comprehensive metabolic panel | 1.9% | 8,827 | 7,329 | $150K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.6% | 1,085 | 884 | $125K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 8,400 | 6,845 | $107K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.1% | 904 | 776 | $89K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.1% | 1,296 | 949 | $85K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 996 | 928 | $71K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,678 | 4,538 | $36K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,008 | 815 | $36K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,126 | 999 | $35K |
43 more codes
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 842 | $28K |
| 71045 | Radiologic examination, chest; single view | <1% | 445 | $24K |
| 81001 | <1% | 1,793 | $23K | |
| 96152 | <1% | 184 | $19K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 209 | $19K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 106 | $15K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 438 | $9K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 51 | $8K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 190 | $8K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 973 | $7K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 175 | $5K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 66 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 381 | $4K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 63 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 206 | $3K |
| 83690 | <1% | 148 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 29 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 33 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 102 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 25 | $2K |
| 84484 | <1% | 72 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 48 | $2K |
| 80061 | Lipid panel | <1% | 188 | $2K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 13 | $2K |
| 85027 | <1% | 154 | $2K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 59 | $2K |
| 87070 | <1% | 61 | $1K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 376 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 74 | $1K |
| 83516 | <1% | 28 | $668.72 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 12 | $645.28 |
| 83605 | <1% | 33 | $521.47 | |
| 80076 | <1% | 13 | $360.36 | |
| 81003 | <1% | 143 | $326.52 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 27 | $311.85 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 31 | $303.04 |
| 82607 | <1% | 12 | $302.82 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 12 | $301.35 |
| 82728 | <1% | 46 | $292.17 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 12 | $278.67 |
| 90686 | <1% | 13 | $231.29 | |
| 85610 | <1% | 12 | $175.22 | |
| 83735 | <1% | 28 | $15.24 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANDERSON, DONALD (ASSISTANT SECRETARY ENROLLMENTS)
Parent organizationPROVIDENCE HEALTH & SERVICES OREGON
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.